Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Budesonide (BUD) Market Growth 2022-2028

  • LP 4791541
  • 108 Pages
  • January 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Budesonide (BUD) will have significant change from previous year. According to our (LP Information) latest study, the global Budesonide (BUD) market size is USD million in 2022 from USD 8024.6 million in 2021, with a change of % between 2021 and 2022. The global Budesonide (BUD) market size will reach USD 10040 million in 2028, growing at a CAGR of 3.3% over the analysis period.

The United States Budesonide (BUD) market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Budesonide (BUD) market, reaching US$ million by the year 2028. As for the Europe Budesonide (BUD) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Budesonide (BUD) players cover AstraZeneca, Cosmo Pharmaceuticals, Teva, and Mylan, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Budesonide (BUD) market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Nasal Spray

Inhaler

Pill

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Respiratory Disease Treatment

Nose Disease Treatment

Inflammatory Bowel Disease Treatment

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

AstraZeneca

Cosmo Pharmaceuticals

Teva

Mylan

Sandoz

Dr. Falk Pharma

Chiesi Farmaceutici

Orion

Cipla

Synmosa Biopharma

Lunan Better Pharmaceutical

Shanghai Sine Promod Pharmaceutical

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Budesonide (BUD) Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Budesonide (BUD) by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Budesonide (BUD) by Country/Region, 2017, 2022 & 2028

2.2 Budesonide (BUD) Segment by Type

2.2.1 Nasal Spray

2.2.2 Inhaler

2.2.3 Pill

2.3 Budesonide (BUD) Sales by Type

2.3.1 Global Budesonide (BUD) Sales Market Share by Type (2017-2022)

2.3.2 Global Budesonide (BUD) Revenue and Market Share by Type (2017-2022)

2.3.3 Global Budesonide (BUD) Sale Price by Type (2017-2022)

2.4 Budesonide (BUD) Segment by Application

2.4.1 Respiratory Disease Treatment

2.4.2 Nose Disease Treatment

2.4.3 Inflammatory Bowel Disease Treatment

2.5 Budesonide (BUD) Sales by Application

2.5.1 Global Budesonide (BUD) Sale Market Share by Application (2017-2022)

2.5.2 Global Budesonide (BUD) Revenue and Market Share by Application (2017-2022)

2.5.3 Global Budesonide (BUD) Sale Price by Application (2017-2022)

3 Global Budesonide (BUD) by Company

3.1 Global Budesonide (BUD) Breakdown Data by Company

3.1.1 Global Budesonide (BUD) Annual Sales by Company (2020-2022)

3.1.2 Global Budesonide (BUD) Sales Market Share by Company (2020-2022)

3.2 Global Budesonide (BUD) Annual Revenue by Company (2020-2022)

3.2.1 Global Budesonide (BUD) Revenue by Company (2020-2022)

3.2.2 Global Budesonide (BUD) Revenue Market Share by Company (2020-2022)

3.3 Global Budesonide (BUD) Sale Price by Company

3.4 Key Manufacturers Budesonide (BUD) Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Budesonide (BUD) Product Location Distribution

3.4.2 Players Budesonide (BUD) Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Budesonide (BUD) by Geographic Region

4.1 World Historic Budesonide (BUD) Market Size by Geographic Region (2017-2022)

4.1.1 Global Budesonide (BUD) Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Budesonide (BUD) Annual Revenue by Geographic Region

4.2 World Historic Budesonide (BUD) Market Size by Country/Region (2017-2022)

4.2.1 Global Budesonide (BUD) Annual Sales by Country/Region (2017-2022)

4.2.2 Global Budesonide (BUD) Annual Revenue by Country/Region

4.3 Americas Budesonide (BUD) Sales Growth

4.4 APAC Budesonide (BUD) Sales Growth

4.5 Europe Budesonide (BUD) Sales Growth

4.6 Middle East & Africa Budesonide (BUD) Sales Growth

5 Americas

5.1 Americas Budesonide (BUD) Sales by Country

5.1.1 Americas Budesonide (BUD) Sales by Country (2017-2022)

5.1.2 Americas Budesonide (BUD) Revenue by Country (2017-2022)

5.2 Americas Budesonide (BUD) Sales by Type

5.3 Americas Budesonide (BUD) Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Budesonide (BUD) Sales by Region

6.1.1 APAC Budesonide (BUD) Sales by Region (2017-2022)

6.1.2 APAC Budesonide (BUD) Revenue by Region (2017-2022)

6.2 APAC Budesonide (BUD) Sales by Type

6.3 APAC Budesonide (BUD) Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Budesonide (BUD) by Country

7.1.1 Europe Budesonide (BUD) Sales by Country (2017-2022)

7.1.2 Europe Budesonide (BUD) Revenue by Country (2017-2022)

7.2 Europe Budesonide (BUD) Sales by Type

7.3 Europe Budesonide (BUD) Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Budesonide (BUD) by Country

8.1.1 Middle East & Africa Budesonide (BUD) Sales by Country (2017-2022)

8.1.2 Middle East & Africa Budesonide (BUD) Revenue by Country (2017-2022)

8.2 Middle East & Africa Budesonide (BUD) Sales by Type

8.3 Middle East & Africa Budesonide (BUD) Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Budesonide (BUD)

10.3 Manufacturing Process Analysis of Budesonide (BUD)

10.4 Industry Chain Structure of Budesonide (BUD)

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Budesonide (BUD) Distributors

11.3 Budesonide (BUD) Customer

12 World Forecast Review for Budesonide (BUD) by Geographic Region

12.1 Global Budesonide (BUD) Market Size Forecast by Region

12.1.1 Global Budesonide (BUD) Forecast by Region (2023-2028)

12.1.2 Global Budesonide (BUD) Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Budesonide (BUD) Forecast by Type

12.7 Global Budesonide (BUD) Forecast by Application

13 Key Players Analysis

13.1 AstraZeneca

13.1.1 AstraZeneca Company Information

13.1.2 AstraZeneca Budesonide (BUD) Product Offered

13.1.3 AstraZeneca Budesonide (BUD) Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 AstraZeneca Main Business Overview

13.1.5 AstraZeneca Latest Developments

13.2 Cosmo Pharmaceuticals

13.2.1 Cosmo Pharmaceuticals Company Information

13.2.2 Cosmo Pharmaceuticals Budesonide (BUD) Product Offered

13.2.3 Cosmo Pharmaceuticals Budesonide (BUD) Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Cosmo Pharmaceuticals Main Business Overview

13.2.5 Cosmo Pharmaceuticals Latest Developments

13.3 Teva

13.3.1 Teva Company Information

13.3.2 Teva Budesonide (BUD) Product Offered

13.3.3 Teva Budesonide (BUD) Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Teva Main Business Overview

13.3.5 Teva Latest Developments

13.4 Mylan

13.4.1 Mylan Company Information

13.4.2 Mylan Budesonide (BUD) Product Offered

13.4.3 Mylan Budesonide (BUD) Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Mylan Main Business Overview

13.4.5 Mylan Latest Developments

13.5 Sandoz

13.5.1 Sandoz Company Information

13.5.2 Sandoz Budesonide (BUD) Product Offered

13.5.3 Sandoz Budesonide (BUD) Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Sandoz Main Business Overview

13.5.5 Sandoz Latest Developments

13.6 Dr. Falk Pharma

13.6.1 Dr. Falk Pharma Company Information

13.6.2 Dr. Falk Pharma Budesonide (BUD) Product Offered

13.6.3 Dr. Falk Pharma Budesonide (BUD) Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Dr. Falk Pharma Main Business Overview

13.6.5 Dr. Falk Pharma Latest Developments

13.7 Chiesi Farmaceutici

13.7.1 Chiesi Farmaceutici Company Information

13.7.2 Chiesi Farmaceutici Budesonide (BUD) Product Offered

13.7.3 Chiesi Farmaceutici Budesonide (BUD) Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Chiesi Farmaceutici Main Business Overview

13.7.5 Chiesi Farmaceutici Latest Developments

13.8 Orion

13.8.1 Orion Company Information

13.8.2 Orion Budesonide (BUD) Product Offered

13.8.3 Orion Budesonide (BUD) Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Orion Main Business Overview

13.8.5 Orion Latest Developments

13.9 Cipla

13.9.1 Cipla Company Information

13.9.2 Cipla Budesonide (BUD) Product Offered

13.9.3 Cipla Budesonide (BUD) Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Cipla Main Business Overview

13.9.5 Cipla Latest Developments

13.10 Synmosa Biopharma

13.10.1 Synmosa Biopharma Company Information

13.10.2 Synmosa Biopharma Budesonide (BUD) Product Offered

13.10.3 Synmosa Biopharma Budesonide (BUD) Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Synmosa Biopharma Main Business Overview

13.10.5 Synmosa Biopharma Latest Developments

13.11 Lunan Better Pharmaceutical

13.11.1 Lunan Better Pharmaceutical Company Information

13.11.2 Lunan Better Pharmaceutical Budesonide (BUD) Product Offered

13.11.3 Lunan Better Pharmaceutical Budesonide (BUD) Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Lunan Better Pharmaceutical Main Business Overview

13.11.5 Lunan Better Pharmaceutical Latest Developments

13.12 Shanghai Sine Promod Pharmaceutical

13.12.1 Shanghai Sine Promod Pharmaceutical Company Information

13.12.2 Shanghai Sine Promod Pharmaceutical Budesonide (BUD) Product Offered

13.12.3 Shanghai Sine Promod Pharmaceutical Budesonide (BUD) Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Shanghai Sine Promod Pharmaceutical Main Business Overview

13.12.5 Shanghai Sine Promod Pharmaceutical Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Budesonide (BUD) Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Budesonide (BUD) Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Nasal Spray

Table 4. Major Players of Inhaler

Table 5. Major Players of Pill

Table 6. Global Budesonide (BUD) Sales by Type (2017-2022) & (K MT)

Table 7. Global Budesonide (BUD) Sales Market Share by Type (2017-2022)

Table 8. Global Budesonide (BUD) Revenue by Type (2017-2022) & ($ million)

Table 9. Global Budesonide (BUD) Revenue Market Share by Type (2017-2022)

Table 10. Global Budesonide (BUD) Sale Price by Type (2017-2022) & (USD/MT)

Table 11. Global Budesonide (BUD) Sales by Application (2017-2022) & (K MT)

Table 12. Global Budesonide (BUD) Sales Market Share by Application (2017-2022)

Table 13. Global Budesonide (BUD) Revenue by Application (2017-2022)

Table 14. Global Budesonide (BUD) Revenue Market Share by Application (2017-2022)

Table 15. Global Budesonide (BUD) Sale Price by Application (2017-2022) & (USD/MT)

Table 16. Global Budesonide (BUD) Sales by Company (2020-2022) & (K MT)

Table 17. Global Budesonide (BUD) Sales Market Share by Company (2020-2022)

Table 18. Global Budesonide (BUD) Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Budesonide (BUD) Revenue Market Share by Company (2020-2022)

Table 20. Global Budesonide (BUD) Sale Price by Company (2020-2022) & (USD/MT)

Table 21. Key Manufacturers Budesonide (BUD) Producing Area Distribution and Sales Area

Table 22. Players Budesonide (BUD) Products Offered

Table 23. Budesonide (BUD) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Budesonide (BUD) Sales by Geographic Region (2017-2022) & (K MT)

Table 27. Global Budesonide (BUD) Sales Market Share Geographic Region (2017-2022)

Table 28. Global Budesonide (BUD) Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Budesonide (BUD) Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Budesonide (BUD) Sales by Country/Region (2017-2022) & (K MT)

Table 31. Global Budesonide (BUD) Sales Market Share by Country/Region (2017-2022)

Table 32. Global Budesonide (BUD) Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Budesonide (BUD) Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Budesonide (BUD) Sales by Country (2017-2022) & (K MT)

Table 35. Americas Budesonide (BUD) Sales Market Share by Country (2017-2022)

Table 36. Americas Budesonide (BUD) Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Budesonide (BUD) Revenue Market Share by Country (2017-2022)

Table 38. Americas Budesonide (BUD) Sales by Type (2017-2022) & (K MT)

Table 39. Americas Budesonide (BUD) Sales Market Share by Type (2017-2022)

Table 40. Americas Budesonide (BUD) Sales by Application (2017-2022) & (K MT)

Table 41. Americas Budesonide (BUD) Sales Market Share by Application (2017-2022)

Table 42. APAC Budesonide (BUD) Sales by Region (2017-2022) & (K MT)

Table 43. APAC Budesonide (BUD) Sales Market Share by Region (2017-2022)

Table 44. APAC Budesonide (BUD) Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Budesonide (BUD) Revenue Market Share by Region (2017-2022)

Table 46. APAC Budesonide (BUD) Sales by Type (2017-2022) & (K MT)

Table 47. APAC Budesonide (BUD) Sales Market Share by Type (2017-2022)

Table 48. APAC Budesonide (BUD) Sales by Application (2017-2022) & (K MT)

Table 49. APAC Budesonide (BUD) Sales Market Share by Application (2017-2022)

Table 50. Europe Budesonide (BUD) Sales by Country (2017-2022) & (K MT)

Table 51. Europe Budesonide (BUD) Sales Market Share by Country (2017-2022)

Table 52. Europe Budesonide (BUD) Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Budesonide (BUD) Revenue Market Share by Country (2017-2022)

Table 54. Europe Budesonide (BUD) Sales by Type (2017-2022) & (K MT)

Table 55. Europe Budesonide (BUD) Sales Market Share by Type (2017-2022)

Table 56. Europe Budesonide (BUD) Sales by Application (2017-2022) & (K MT)

Table 57. Europe Budesonide (BUD) Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Budesonide (BUD) Sales by Country (2017-2022) & (K MT)

Table 59. Middle East & Africa Budesonide (BUD) Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Budesonide (BUD) Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Budesonide (BUD) Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Budesonide (BUD) Sales by Type (2017-2022) & (K MT)

Table 63. Middle East & Africa Budesonide (BUD) Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Budesonide (BUD) Sales by Application (2017-2022) & (K MT)

Table 65. Middle East & Africa Budesonide (BUD) Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Budesonide (BUD)

Table 67. Key Market Challenges & Risks of Budesonide (BUD)

Table 68. Key Industry Trends of Budesonide (BUD)

Table 69. Budesonide (BUD) Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Budesonide (BUD) Distributors List

Table 72. Budesonide (BUD) Customer List

Table 73. Global Budesonide (BUD) Sales Forecast by Region (2023-2028) & (K MT)

Table 74. Global Budesonide (BUD) Sales Market Forecast by Region

Table 75. Global Budesonide (BUD) Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Budesonide (BUD) Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Budesonide (BUD) Sales Forecast by Country (2023-2028) & (K MT)

Table 78. Americas Budesonide (BUD) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Budesonide (BUD) Sales Forecast by Region (2023-2028) & (K MT)

Table 80. APAC Budesonide (BUD) Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Budesonide (BUD) Sales Forecast by Country (2023-2028) & (K MT)

Table 82. Europe Budesonide (BUD) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Budesonide (BUD) Sales Forecast by Country (2023-2028) & (K MT)

Table 84. Middle East & Africa Budesonide (BUD) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Budesonide (BUD) Sales Forecast by Type (2023-2028) & (K MT)

Table 86. Global Budesonide (BUD) Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Budesonide (BUD) Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Budesonide (BUD) Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Budesonide (BUD) Sales Forecast by Application (2023-2028) & (K MT)

Table 90. Global Budesonide (BUD) Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Budesonide (BUD) Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Budesonide (BUD) Revenue Market Share Forecast by Application (2023-2028)

Table 93. AstraZeneca Basic Information, Budesonide (BUD) Manufacturing Base, Sales Area and Its Competitors

Table 94. AstraZeneca Budesonide (BUD) Product Offered

Table 95. AstraZeneca Budesonide (BUD) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 96. AstraZeneca Main Business

Table 97. AstraZeneca Latest Developments

Table 98. Cosmo Pharmaceuticals Basic Information, Budesonide (BUD) Manufacturing Base, Sales Area and Its Competitors

Table 99. Cosmo Pharmaceuticals Budesonide (BUD) Product Offered

Table 100. Cosmo Pharmaceuticals Budesonide (BUD) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 101. Cosmo Pharmaceuticals Main Business

Table 102. Cosmo Pharmaceuticals Latest Developments

Table 103. Teva Basic Information, Budesonide (BUD) Manufacturing Base, Sales Area and Its Competitors

Table 104. Teva Budesonide (BUD) Product Offered

Table 105. Teva Budesonide (BUD) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 106. Teva Main Business

Table 107. Teva Latest Developments

Table 108. Mylan Basic Information, Budesonide (BUD) Manufacturing Base, Sales Area and Its Competitors

Table 109. Mylan Budesonide (BUD) Product Offered

Table 110. Mylan Budesonide (BUD) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 111. Mylan Main Business

Table 112. Mylan Latest Developments

Table 113. Sandoz Basic Information, Budesonide (BUD) Manufacturing Base, Sales Area and Its Competitors

Table 114. Sandoz Budesonide (BUD) Product Offered

Table 115. Sandoz Budesonide (BUD) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 116. Sandoz Main Business

Table 117. Sandoz Latest Developments

Table 118. Dr. Falk Pharma Basic Information, Budesonide (BUD) Manufacturing Base, Sales Area and Its Competitors

Table 119. Dr. Falk Pharma Budesonide (BUD) Product Offered

Table 120. Dr. Falk Pharma Budesonide (BUD) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 121. Dr. Falk Pharma Main Business

Table 122. Dr. Falk Pharma Latest Developments

Table 123. Chiesi Farmaceutici Basic Information, Budesonide (BUD) Manufacturing Base, Sales Area and Its Competitors

Table 124. Chiesi Farmaceutici Budesonide (BUD) Product Offered

Table 125. Chiesi Farmaceutici Budesonide (BUD) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 126. Chiesi Farmaceutici Main Business

Table 127. Chiesi Farmaceutici Latest Developments

Table 128. Orion Basic Information, Budesonide (BUD) Manufacturing Base, Sales Area and Its Competitors

Table 129. Orion Budesonide (BUD) Product Offered

Table 130. Orion Budesonide (BUD) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 131. Orion Main Business

Table 132. Orion Latest Developments

Table 133. Cipla Basic Information, Budesonide (BUD) Manufacturing Base, Sales Area and Its Competitors

Table 134. Cipla Budesonide (BUD) Product Offered

Table 135. Cipla Budesonide (BUD) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 136. Cipla Main Business

Table 137. Cipla Latest Developments

Table 138. Synmosa Biopharma Basic Information, Budesonide (BUD) Manufacturing Base, Sales Area and Its Competitors

Table 139. Synmosa Biopharma Budesonide (BUD) Product Offered

Table 140. Synmosa Biopharma Budesonide (BUD) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 141. Synmosa Biopharma Main Business

Table 142. Synmosa Biopharma Latest Developments

Table 143. Lunan Better Pharmaceutical Basic Information, Budesonide (BUD) Manufacturing Base, Sales Area and Its Competitors

Table 144. Lunan Better Pharmaceutical Budesonide (BUD) Product Offered

Table 145. Lunan Better Pharmaceutical Budesonide (BUD) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 146. Lunan Better Pharmaceutical Main Business

Table 147. Lunan Better Pharmaceutical Latest Developments

Table 148. Shanghai Sine Promod Pharmaceutical Basic Information, Budesonide (BUD) Manufacturing Base, Sales Area and Its Competitors

Table 149. Shanghai Sine Promod Pharmaceutical Budesonide (BUD) Product Offered

Table 150. Shanghai Sine Promod Pharmaceutical Budesonide (BUD) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 151. Shanghai Sine Promod Pharmaceutical Main Business

Table 152. Shanghai Sine Promod Pharmaceutical Latest Developments

List of Figures

Figure 1. Picture of Budesonide (BUD)

Figure 2. Budesonide (BUD) Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Budesonide (BUD) Sales Growth Rate 2017-2028 (K MT)

Figure 7. Global Budesonide (BUD) Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Budesonide (BUD) Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Nasal Spray

Figure 10. Product Picture of Inhaler

Figure 11. Product Picture of Pill

Figure 12. Global Budesonide (BUD) Sales Market Share by Type in 2021

Figure 13. Global Budesonide (BUD) Revenue Market Share by Type (2017-2022)

Figure 14. Budesonide (BUD) Consumed in Respiratory Disease Treatment

Figure 15. Global Budesonide (BUD) Market: Respiratory Disease Treatment (2017-2022) & (K MT)

Figure 16. Budesonide (BUD) Consumed in Nose Disease Treatment

Figure 17. Global Budesonide (BUD) Market: Nose Disease Treatment (2017-2022) & (K MT)

Figure 18. Budesonide (BUD) Consumed in Inflammatory Bowel Disease Treatment

Figure 19. Global Budesonide (BUD) Market: Inflammatory Bowel Disease Treatment (2017-2022) & (K MT)

Figure 20. Global Budesonide (BUD) Sales Market Share by Application (2017-2022)

Figure 21. Global Budesonide (BUD) Revenue Market Share by Application in 2021

Figure 22. Budesonide (BUD) Revenue Market by Company in 2021 ($ Million)

Figure 23. Global Budesonide (BUD) Revenue Market Share by Company in 2021

Figure 24. Global Budesonide (BUD) Sales Market Share by Geographic Region (2017-2022)

Figure 25. Global Budesonide (BUD) Revenue Market Share by Geographic Region in 2021

Figure 26. Global Budesonide (BUD) Sales Market Share by Region (2017-2022)

Figure 27. Global Budesonide (BUD) Revenue Market Share by Country/Region in 2021

Figure 28. Americas Budesonide (BUD) Sales 2017-2022 (K MT)

Figure 29. Americas Budesonide (BUD) Revenue 2017-2022 ($ Millions)

Figure 30. APAC Budesonide (BUD) Sales 2017-2022 (K MT)

Figure 31. APAC Budesonide (BUD) Revenue 2017-2022 ($ Millions)

Figure 32. Europe Budesonide (BUD) Sales 2017-2022 (K MT)

Figure 33. Europe Budesonide (BUD) Revenue 2017-2022 ($ Millions)

Figure 34. Middle East & Africa Budesonide (BUD) Sales 2017-2022 (K MT)

Figure 35. Middle East & Africa Budesonide (BUD) Revenue 2017-2022 ($ Millions)

Figure 36. Americas Budesonide (BUD) Sales Market Share by Country in 2021

Figure 37. Americas Budesonide (BUD) Revenue Market Share by Country in 2021

Figure 38. United States Budesonide (BUD) Revenue Growth 2017-2022 ($ Millions)

Figure 39. Canada Budesonide (BUD) Revenue Growth 2017-2022 ($ Millions)

Figure 40. Mexico Budesonide (BUD) Revenue Growth 2017-2022 ($ Millions)

Figure 41. Brazil Budesonide (BUD) Revenue Growth 2017-2022 ($ Millions)

Figure 42. APAC Budesonide (BUD) Sales Market Share by Region in 2021

Figure 43. APAC Budesonide (BUD) Revenue Market Share by Regions in 2021

Figure 44. China Budesonide (BUD) Revenue Growth 2017-2022 ($ Millions)

Figure 45. Japan Budesonide (BUD) Revenue Growth 2017-2022 ($ Millions)

Figure 46. South Korea Budesonide (BUD) Revenue Growth 2017-2022 ($ Millions)

Figure 47. Southeast Asia Budesonide (BUD) Revenue Growth 2017-2022 ($ Millions)

Figure 48. India Budesonide (BUD) Revenue Growth 2017-2022 ($ Millions)

Figure 49. Australia Budesonide (BUD) Revenue Growth 2017-2022 ($ Millions)

Figure 50. Europe Budesonide (BUD) Sales Market Share by Country in 2021

Figure 51. Europe Budesonide (BUD) Revenue Market Share by Country in 2021

Figure 52. Germany Budesonide (BUD) Revenue Growth 2017-2022 ($ Millions)

Figure 53. France Budesonide (BUD) Revenue Growth 2017-2022 ($ Millions)

Figure 54. UK Budesonide (BUD) Revenue Growth 2017-2022 ($ Millions)

Figure 55. Italy Budesonide (BUD) Revenue Growth 2017-2022 ($ Millions)

Figure 56. Russia Budesonide (BUD) Revenue Growth 2017-2022 ($ Millions)

Figure 57. Middle East & Africa Budesonide (BUD) Sales Market Share by Country in 2021

Figure 58. Middle East & Africa Budesonide (BUD) Revenue Market Share by Country in 2021

Figure 59. Egypt Budesonide (BUD) Revenue Growth 2017-2022 ($ Millions)

Figure 60. South Africa Budesonide (BUD) Revenue Growth 2017-2022 ($ Millions)

Figure 61. Israel Budesonide (BUD) Revenue Growth 2017-2022 ($ Millions)

Figure 62. Turkey Budesonide (BUD) Revenue Growth 2017-2022 ($ Millions)

Figure 63. GCC Country Budesonide (BUD) Revenue Growth 2017-2022 ($ Millions)

Figure 64. Manufacturing Cost Structure Analysis of Budesonide (BUD) in 2021

Figure 65. Manufacturing Process Analysis of Budesonide (BUD)

Figure 66. Industry Chain Structure of Budesonide (BUD)

Figure 67. Channels of Distribution

Figure 68. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390